Prognostic Value of Lactate Dehydrogenase in Advanced Esophageal Squamous Cell Carcinoma Patients with Immunotherapy

Prognostic Value of Lactate Dehydrogenase in Advanced Esophageal Squamous Cell Carcinoma Patients with Immunotherapy

Background The overall efficacy of immunotherapy is unsatisfactory in patients with advanced esophageal squamous cell carcinoma (ESCC) , since only a few cases could obtain benefits from the therapy. Therefore, it is of great importance to select effective prognostic indicators. Objective To investi...

Full description

Bibliographic Details
Main Author:	Yan LI, Kunlun WANG, Hui YANG, Erjiang ZHAO, Bingxu LI, Shenglei LI, Xiaotao DONG, Ling YUAN
Format:	Article
Language:	zho
Published:	Chinese General Practice Publishing House Co., Ltd 2022-09-01
Series:	Zhongguo quanke yixue
Subjects:	esophageal neoplasms\|esophageal squamous cell carcinoma\|immunotherapy\|programmed death -1\|lactate dehydrogenases\|clinical reaction\|prognosis\|progress-free survival\|overall survival
Online Access:	https://www.chinagp.net/fileup/1007-9572/PDF/1658364679583-243027300.pdf

Similar Items

Prognostic Value of Lactate Dehydrogenase in Second-Line Immunotherapy for Advanced Esophageal Squamous Cell Carcinoma
by: Yan Li, et al.
Published: (2022-06-01)

Immunotherapy with or without radiotherapy for metastatic or recurrent esophageal squamous cell carcinoma: A real-world study
by: Xiaoyue Wu, et al.
Published: (2023-01-01)

Prognostic value of lactate dehydrogenase to albumin ratio (LAR) in patients with resectable esophageal squamous cell carcinoma
by: Feng JF, et al.
Published: (2019-07-01)

Benefit of chemotherapy based on platinum with definitive radiotherapy in older patients with locally advanced esophageal squamous cell carcinoma
by: Haishan Wu, et al.
Published: (2021-10-01)

Progression‐free survival at 3 years is a reliable surrogate for 5‐year overall survival for patients suffering from locally advanced esophageal squamous cell carcinoma
by: Yu‐Xian Yang, et al.
Published: (2022-10-01)

Can <sup>18</sup>F-FDG PET/CT Radiomics Features Predict Clinical Outcomes in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma?
by: Vetri Sudar Jayaprakasam, et al.
Published: (2022-06-01)

A Clinical Scoring Model to Predict the Effect of Induction Chemotherapy With Definitive Concurrent Chemoradiotherapy on Esophageal Squamous Cell Carcinoma Prognosis
by: Yang Li, et al.
Published: (2021-11-01)

Outcomes of concurrent chemoradiotherapy versus chemotherapy alone for stage IV esophageal squamous cell carcinoma: a retrospective controlled study
by: Jiahua Lyu, et al.
Published: (2018-11-01)

Machine learning models predict overall survival and progression free survival of non-surgical esophageal cancer patients with chemoradiotherapy based on CT image radiomics signatures
by: Yongbin Cui, et al.
Published: (2022-12-01)

Lactate dehydrogenase and baseline markers associated with clinical outcomes of advanced esophageal squamous cell carcinoma patients treated with camrelizumab (SHR‐1210), a novel anti‐PD‐1 antibody
by: Xi Wang, et al.
Published: (2019-06-01)

Efficacy and safety of anti-PD-1 antibody plus chemoradiotherapy in locally advanced esophageal squamous cancer
by: Ji Ma, et al.
Published: (2023-02-01)

Identification of the Prognostic Value of Tumor Microenvironment-Related Genes in Esophageal Squamous Cell Carcinoma
by: Donglei Zhang, et al.
Published: (2020-12-01)

Increases prognostic value of clinical-pathological nomogram in patients with esophageal squamous cell carcinoma
by: Jing Feng Hu, et al.
Published: (2023-02-01)

Prognostic significance of lactate dehydrogenase and its impact on the outcomes of gastric cancer: a systematic review and meta-analysis
by: Jinjin Chen, et al.
Published: (2023-09-01)

Smoking behavior and smoking index as prognostic indicators for patients with esophageal squamous cell carcinoma who underwent surgery: A large cohort study in Guangzhou, China
by: Lili Liu*, et al.
Published: (2020-02-01)

BAG2 overexpression correlates with growth and poor prognosis of esophageal squamous cell carcinoma
by: Hong Ying-Cai, et al.
Published: (2018-12-01)

Development and validation of a novel prognostic model for patients with surgically resected esophageal squamous cell carcinoma
by: Haiyang Hu, et al.
Published: (2022-08-01)

Identifying LATS2 as a prognostic biomarker relevant to immune infiltrates in human esophageal squamous cell carcinoma
by: Minqi Zhu, et al.
Published: (2022-09-01)

Development and validation of a nomogram to predict overall survival of T1 esophageal squamous cell carcinoma patients with lymph node metastasis
by: Jia Yu, et al.
Published: (2021-08-01)

Evaluation of Lactate Dehydrogenase and Alkaline Phosphatase as Predictive Biomarkers in the Prognosis of Hepatocellular Carcinoma and Development of a New Nomogram
by: Su K, et al.
Published: (2023-01-01)

Expression and clinical significance of phosphorylated FGFR1Y654 in esophageal squamous cell carcinoma
by: DU Dan, et al.
Published: (2024-02-01)

Clinical value of folate receptor-positive circulating tumor cells in patients with esophageal squamous cell carcinomas: a retrospective study
by: Qiang Zhou, et al.
Published: (2023-11-01)

Preoperative Prognostic Nutritional Index Predict Survival in Patients With Resectable Esophageal Squamous Cell Carcinoma
by: Zhiwei Zheng, et al.
Published: (2022-04-01)

Association between dietary retinol and prognosis of patients with esophageal squamous cell carcinoma
by: ZENG Qiaoyan, et al.
Published: (2022-11-01)

Arterial chemoembolization for patients with hepatocellular carcinoma and elevated lactate dehydrogenase is associated with low survival: a cohort study
by: Genghui Zhuang, et al.
Published: (2022-06-01)

Prognostic significance of lymphovascular invasion in patients with pT1b esophageal squamous cell carcinoma
by: Linxiu Liu, et al.
Published: (2023-04-01)

Immunohistochemical prognostic markers of esophageal squamous cell carcinoma: a systematic review
by: Chunni Wang, et al.
Published: (2017-08-01)

Post-treatment serum triglyceride: An effective biomarker for body fat mass and overall survival in esophageal squamous cell cancer patients treated with chemoradiotherapy
by: Jiahua Lyu, et al.
Published: (2022-12-01)

A composite indicator of derived neutrophil–lymphocyte ratio and lactate dehydrogenase correlates with outcomes in pancreatic carcinoma patients treated with PD-1 inhibitors
by: Shiyun Chen, et al.
Published: (2022-10-01)

Up-regulated serum lactate dehydrogenase could become a poor prognostic marker in patients with bladder cancer by an evidence-based analysis of 2,182 patients
by: Xiaoyu Wei, et al.
Published: (2023-08-01)

Co-expression of High-mobility group box 1 protein (HMGB1) and receptor for advanced glycation end products (RAGE) in the prognosis of esophageal squamous cell carcinoma
by: Lingzhao Li, et al.
Published: (2022-07-01)

A Radiomics Nomogram for Non-Invasive Prediction of Progression-Free Survival in Esophageal Squamous Cell Carcinoma
by: Ting Yan, et al.
Published: (2022-05-01)

Wnt signaling pathway-related gene PRICKLE1 is a prognostic biomarker for esophageal squamous cell carcinoma
by: Jinxian He, et al.
Published: (2023-02-01)

Combining Lactate Dehydrogenase and Fibrinogen: Potential Factors to Predict Therapeutic Efficacy and Prognosis of Patients with Small-Cell Lung Cancer
by: Huang W, et al.
Published: (2021-05-01)

The prognostic value of tumor length to resectable esophageal squamous cell carcinoma: a retrospective study
by: Xiangwei Zhang, et al.
Published: (2017-01-01)

Overall Survival for Esophageal Squamous Cell Carcinoma with Multiple Primary Cancers after Curative Esophagectomy—A Retrospective Single-Institution Study
by: Ping-Chung Tsai, et al.
Published: (2022-10-01)

The Role of Adjuvant Chemoradiotherapy Over Radiotherapy After R0 Resection for Stage II-III Esophageal Squamous Cell Carcinoma
by: Song T, et al.
Published: (2020-03-01)

Anlotinib for previously treated advanced or metastatic esophageal squamous cell carcinoma: A double‐blind randomized phase 2 trial
by: Jing Huang, et al.
Published: (2021-03-01)

Factors affecting survival in esophageal squamous cell carcinoma: Single-center experience
by: Abdullah Sakin, et al.
Published: (2020-05-01)

CT-based radiomics combined with hematologic parameters for survival prediction in locally advanced esophageal cancer patients receiving definitive chemoradiotherapy
by: Jinfeng Cui, et al.
Published: (2024-03-01)